Price Alert: Shares of Avadel (AVDL) Trade 23.45% Higher at Midday August 5

Equities Staff  |

Shares of Avadel Pharmaceuticals plc - ADR (NASDAQ: AVDL) rose 23.45% Friday.

As of 11:48:16 est, Avadel sits at $5.82 and has moved $1.1 per share in trading so far.

Avadel has moved 43.89% over the last 30 days and has moved YTD 35.89% based on the most recent close.

The company anticipates its next earnings on 2022-08-08.

For technical charts, analysis, and more on Avadel visit the company profile.

About Avadel Pharmaceuticals plc - ADR

Avadel Pharmaceuticals plc is a biopharmaceutical company primarily focused on the development and FDA approval of FT218, an investigational, once-nightly, extended-release formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy.

To get more information on Avadel Pharmaceuticals plc - ADR and to follow the company's latest updates, you can visit the company's profile page here: Avadel Pharmaceuticals plc - ADR's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation



Market Movers

Sponsored Financial Content